Indian shares flat as pharma boost offsets losses in tech stocks
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/06/bc7b0d305093bb8cffe63fe85e48df44.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
BENGALURU - Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks.
By 0414 GMT, the blue-chip NSE Nifty 50 index was up 0.04% at 15,866.95 and the benchmark S&P BSE Sensex rose 0.02% to 52,936.01.
Both the indexes added more than 1% last week, when the country's vaccinations averaged six million doses per day and some pandemic-induced restrictions were eased further.
On Monday, India reported its lowest increase in COVID-19 deaths since mid-April.
In Mumbai trading, the Nifty Pharma index rose 0.77%, while conglomerate Reliance Industries gained 0.4% after four sessions of losses.
The Nifty IT index fell 0.43% after two straight sessions of gains.
Among global markets, broader Asian shares kicked off the week on a cautious note as a spike in coronavirus cases across the weekend hurt investor sentiment. [MKTS/GLOB]
(Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V)
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)